Advertisement

Reactions Weekly

, Volume 1153, Issue 1, pp 2–2 | Cite as

Novartis advises of updated prescribing information for Exjade

News item
  • 13 Downloads

Keywords

Neutropenia Vasculitis Urticaria Serum Creatinine Level Angioedema 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

REFERENCE

  1. 1.
    Novartis.Important information about Exjade (Rm) (deferasirox) tablets for oral suspension. Internet Document: [4 pages], 14 May 2007. Available from: URL: http://www.fda.gov

Copyright information

© Adis International limited or Adis Data Information BV 2007

Personalised recommendations